599 related articles for article (PubMed ID: 17725907)
1. [Pharmacotherapy for weight loss in patients with type 2 diabetes].
Toubro S
Ugeskr Laeger; 2007 Aug; 169(33):2619-22. PubMed ID: 17725907
[No Abstract] [Full Text] [Related]
2. [Weight reduction. Antiobesity drug treatment in type-2 diabetics].
Verspohl EJ
Pharm Unserer Zeit; 2002; 31(3):300-7. PubMed ID: 12071127
[No Abstract] [Full Text] [Related]
3. [Pharmacotherapy of obesity].
Svendsen OL
Ugeskr Laeger; 2004 Oct; 166(43):3814-7. PubMed ID: 15544112
[No Abstract] [Full Text] [Related]
4. Long-term pharmacotherapy for obesity.
Klein S
Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
[TBL] [Abstract][Full Text] [Related]
5. [New drugs for the treatment of obesity].
Mustajoki P
Duodecim; 1999; 115(20):2191, 2193-4. PubMed ID: 11973921
[No Abstract] [Full Text] [Related]
6. The new role of pharmacotherapy for weight reduction in obesity.
Fernstrom MH; Fernstrom JD
Int J Clin Pract; 2002 Nov; 56(9):683-6. PubMed ID: 12469983
[TBL] [Abstract][Full Text] [Related]
7. New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat.
Scheen AJ; Ernest P
Diabetes Metab; 2002 Dec; 28(6 Pt 1):437-45. PubMed ID: 12522323
[TBL] [Abstract][Full Text] [Related]
8. [What effect does losing weight have on hypertension?].
Engeli S
MMW Fortschr Med; 2003 Jul; 145(27-28):44. PubMed ID: 14587188
[No Abstract] [Full Text] [Related]
9. Medical strategies for weight loss in the overweight and obese patient.
Di Caro S; Hamad GG; Fernstrom MH; Schauer PR; Bonanomi G
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):415-30. PubMed ID: 17108871
[TBL] [Abstract][Full Text] [Related]
10. [A drug help in reducing? Risk profile decides whether and how].
Hauner H
MMW Fortschr Med; 2003 May; 145(21):60. PubMed ID: 12845877
[No Abstract] [Full Text] [Related]
11. Long-term medication use and weight loss maintenance: an observational study.
Womble LG; Wadden TA; Berkowitz RI; Sarwer DB; Rothman RA
Obes Res; 2001 Oct; 9(10):652-3. PubMed ID: 11595785
[No Abstract] [Full Text] [Related]
12. Orlistat and sibutramine beyond weight loss.
Mannucci E; Dicembrini I; Rotella F; Rotella CM
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):342-8. PubMed ID: 17928208
[TBL] [Abstract][Full Text] [Related]
13. Prevention and management of obesity: pharmacology .
Finer N
Proc Nutr Soc; 2000 Aug; 59(3):413. PubMed ID: 10997657
[No Abstract] [Full Text] [Related]
14. New options for drug treatment of obesity in patients with Type 2 diabetes.
Kennedy RL; Khoo EY
Diabet Med; 2005 Sep; 22 Suppl 4():23-6. PubMed ID: 16109016
[No Abstract] [Full Text] [Related]
15. [No progress without the physician in therapy of obesity].
Schmidt H; Plauth M
MMW Fortschr Med; 2000 Jan; 142(4):35-6. PubMed ID: 10850095
[No Abstract] [Full Text] [Related]
16. [Struggle about the best reducing diet, Fat gone by means of more fat?].
Bischoff A
MMW Fortschr Med; 2004 Jan; 146(1-2):4-6. PubMed ID: 18441569
[No Abstract] [Full Text] [Related]
17. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus.
Norris SL; Zhang X; Avenell A; Gregg E; Schmid CH; Lau J
Cochrane Database Syst Rev; 2005 Jan; 2005(1):CD004096. PubMed ID: 15674929
[TBL] [Abstract][Full Text] [Related]
18. [Overweight patient has tried many times to lose weight. What helps against stubborn fat padding?].
Wirth A
MMW Fortschr Med; 2003 Mar; 145(10):16. PubMed ID: 12688021
[No Abstract] [Full Text] [Related]
19. Efficacy of weight loss drugs on obesity and cardiovascular risk factors in obese adolescents: a meta-analysis of randomized controlled trials.
Czernichow S; Lee CM; Barzi F; Greenfield JR; Baur LA; Chalmers J; Woodward M; Huxley RR
Obes Rev; 2010 Feb; 11(2):150-8. PubMed ID: 19573052
[TBL] [Abstract][Full Text] [Related]
20. Current pharmacological approaches to the treatment of obesity.
Hauner H
Int J Obes Relat Metab Disord; 2001 May; 25 Suppl 1():S102-6. PubMed ID: 11466601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
